Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor

scientific article

Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0006-2952(99)00285-3
P698PubMed publication ID10591147
P5875ResearchGate publication ID12710496

P50authorMarc PoirotQ39184526
P2093author name stringBowen WD
Faye JC
Klaebe A
Vilner BJ
Daunes S
Kedjouar B
P2860cites workPhenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expressionQ24313077
Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1)Q24336165
Purification, molecular cloning, and expression of the mammalian sigma1-binding siteQ24619317
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingQ25938984
Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionQ27860958
Microsomal epoxide hydrolase of rat liver is a subunit of theanti-oestrogen-binding siteQ28568639
Physicochemical and genetic evidence for specific antiestrogen binding sitesQ37612930
Modifications of benzylphenoxy ethanamine antiestrogen molecules: influence affinity for antiestrogen binding site (AEBS) and cell cytotoxicityQ40971042
Growth inhibition and apoptosis in human neuroblastoma SK-N-SH cells induced by hypericin, a potent inhibitor of protein kinase C.Q41297623
σ Binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in cultureQ41345642
Synthesis of 2-(p-chlorobenzyl)-3-aryl-6-methoxybenzofurans as selective ligands for antiestrogen-binding sites. Effects on cell proliferation and cholesterol synthesisQ41628454
Increased therapeutic index of antineoplastic drugs in combination with intracellular histamine antagonistsQ42094838
Synthesis, characterization, and biological evaluation of a novel class of N-(arylethyl)-N-alkyl-2-(1-pyrrolidinyl)ethylamines: structural requirements and binding affinity at the .sigma. receptorQ45172168
A new approach to the design of sigma-2-selective ligands: synthesis and evaluation of N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1- pyrrolidinyl)ethylamine-related polyamines at sigma-1 and sigma-2 receptor subtypesQ46220393
Are high-affinity progesterone binding site(s) from porcine liver microsomes members of the sigma receptor family?Q47882555
Pharmacological analysis of sterol delta8-delta7 isomerase proteins with [3H]ifenprodilQ48398727
Comparative affinity of steroidal and non-steroidal antioestrogens, cholesterol derivatives and compounds with a dialkylamino side chain for the rat liver antioestrogen binding site.Q54268084
The anti-proliferative properties of 4-benzylphenoxy ethanamine derivatives are mediated by the anti-estrogen binding site (ABS), whereas the anti-estrogenic effects of trifluopromazine are not.Q54318013
Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.Q55065614
Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability.Q55481341
A proposal for the classification of sigma binding sitesQ67487993
Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzymeQ68100142
Interaction of estradiol and high density lipoproteins on proliferation of the human breast cancer cell line MCF-7 adapted to grow in serum free conditionsQ69974413
A diphenylmethane derivative selective for the anti-estrogen binding site may help define its biological roleQ70816651
Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in cultureQ72210279
N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine in combination with cyclophosphamide: an active, low-toxicity regimen for metastatic hormonally unresponsive prostate cancerQ72240691
Potent interaction of histamine and polyamines at microsomal cytochrome P450, nuclei, and chromatin from rat hepatocytesQ74530792
The intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethamine.HCL, may potentiate doxorubicin in the treatment of metastatic breast cancer: Results of a pilot studyQ77052315
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectcytotoxicityQ246181
P304page(s)1927-1939
P577publication date1999-12-01
P1433published inBiochemical PharmacologyQ864229
P1476titleStructural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor
P478volume58

Reverse relations

cites work (P2860)
Q34068091Identification and pharmacological characterization of cholesterol-5,6-epoxide hydrolase as a target for tamoxifen and AEBS ligands
Q39839020Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism
Q39715988Microsomal epoxide hydrolase expression in the endometrial uterine corpus is regulated by progesterone during the menstrual cycle
Q36427475Molecular and Biochemical Analysis of the Estrogenic and Proliferative Properties of Vitamin E Compounds.
Q44919464Molecular characterization of the microsomal tamoxifen binding site
Q37000551Sigma receptors [σRs]: biology in normal and diseased states
Q72995250Synthesis, binding and structure-affinity studies of new ligands for the microsomal anti-estrogen binding site (AEBS)
Q36321725Tamoxifen induces cellular stress in the nervous system by inhibiting cholesterol synthesis

Search more.